Endotronix Receives FDA Premarket Approval of the Cordella PA Sensor System for the Treatment of Heart Failure
DAIC
JUNE 24, 2024
Reimbursement for implantation and ongoing management through existing reimbursement pathways. "At The company also shared that they have submitted a dossier for CE Mark review and expect a decision on European market access in 2025. Patient visibility into key health trends to support healthy lifestyle changes. later this year.
109 
Let's personalize your content